Residual disease in chronic myeloid leukemia

被引：0

作者：

Dine, G. ^{[1
,2
]}

Rehn, Y. ^{[1
]}

Brahimi, S. ^{[1
]}

Ammar, N. Ali ^{[1
]}

Gaillard, B. ^{[1
]}

Bocq, Y. ^{[1
]}

Fumagalli, G. ^{[1
]}

机构：

[1] Hop Hauts Clos, Serv Hematol Clin & Biol, F-10000 Troyes, France

[2] Ecole Cent Paris, Dept EMV, F-92295 Chatenay Malabry, France

来源：

IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2013年 / 28卷 / 04期

关键词：

Chronic myeloid Leukemia; Chromosome Philadelphia; Tyrosine kinase inhibitors; BCR-ABL transcripts;

D O I：

10.1016/j.immbio.2013.03.006

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：201 / 206

页数：6

共 7 条

[1] Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners [J].

Akard, Luke P. ;

Wang, Y. Lynn .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (05) :385-395

[2]

[Anonymous], 2011, NCCN CHRON MYEL LEUK

[3] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet [J].

Baccarani, Michele ;

Cortes, Jorge ;

Pane, Fabrizio ;

Niederwieser, Dietger ;

Saglio, Giuseppe ;

Apperley, Jane ;

Cervantes, Francisco ;

Deininger, Michael ;

Gratwohl, Alois ;

Guilhot, Francois ;

Hochhaus, Andreas ;

Horowitz, Mary ;

Hughes, Timothy ;

Kantarjian, Hagop ;

Larson, Richard ;

Radich, Jerald ;

Simonsson, Bengt ;

Silver, Richard T. ;

Goldman, John ;

Hehlmann, Rudiger .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6041-6051

[4] Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials [J].

Branford, Susan ;

Fletcher, Linda ;

Cross, Nicholas C. P. ;

Mueller, Martin C. ;

Hochhaus, Andreas ;

Kim, Dong-Wook ;

Radich, Jerald P. ;

Saglio, Giuseppe ;

Pane, Fabrizio ;

Kamel-Reid, Suzanne ;

Wang, Y. Lynn ;

Press, Richard D. ;

Lynch, Kevin ;

Rudzki, Zbigniew ;

Goldman, John M. ;

Hughes, Timothy .

BLOOD, 2008, 112 (08) :3330-3338

[5]

Dine G, 2013, INT J LAB H IN PRESS

[6] Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results [J].

Hughes, Timothy ;

Deininger, Michael ;

Hochhaus, Andreas ;

Branford, Susan ;

Radich, Jerald ;

Kaecla, Jaspal ;

Baccarani, Michele ;

Cortes, Jorge ;

Cross, Nicholas C. P. ;

Druker, Brian J. ;

Gabert, Jean ;

Grimwade, David ;

Hehlmann, Ruediger ;

Kamel-Reid, Suzanne ;

Lipton, Jeffrey H. ;

Longtine, Janina ;

Martinelli, Giovanni ;

Saglio, Giuseppe ;

Soverini, Simona ;

Stock, Wendy ;

Goldman, John M. .

BLOOD, 2006, 108 (01) :28-37

[7] How I monitor residual disease in chronic myeloid leukemia [J].

Radich, Jerald P. .

BLOOD, 2009, 114 (16) :3376-3381

← 1 →